Current updates on generations, approvals, and clinical trials of CAR T-cell therapy

Current updates on generations, approvals, and clinical trials of CAR T-cell therapy

Chimeric antigen receptor (CAR) T-cell therapy is a novel, customized immunotherapy that is considered a ‘living’ and self-replicating drug to treat cancer, sometimes resulting in a complete cure. CAR T-cells are manufactured through genetic engineering of T-cells by equipping them with CARs to dete...

Full description

Bibliographic Details
Main Authors: Tadesse Asmamaw Dejenie, Markeshaw Tiruneh G/Medhin, Gashaw Dessie Terefe, Fitalew Tadele Admasu, Wondwossen Wale Tesega, Endeshaw Chekol Abebe
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
car
car t-cell therapy
structure
generations
approval
clinical trials
Online Access:http://dx.doi.org/10.1080/21645515.2022.2114254

Internet

http://dx.doi.org/10.1080/21645515.2022.2114254

Similar Items